Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial

Kexiang Yan(Fudan University), Fuqiu Li(Second Affiliated Hospital of Jilin University), Xiaodong Bi, Ling Han(Fudan University), Zhenghua Zhang(Fudan University), Rixin Chen, Yu‐Ye Li(Hebei Medical University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Xiao Hua Wang(Southern Medical University), Linfeng Li(Beijing Friendship Hospital), Jianyun Lu(Central South University), Aie Xu(Third People's Hospital of Hangzhou), Sen Yang(Anhui Medical University), Yan Lü(Jiangsu Province Hospital), Jianfang Sun(Chinese Academy of Medical Sciences Dermatology Hospital), Zhiming Li(Wenzhou Medical University), Xiaohong Zhu(Xian Yang Central Hospital), Jiang Meiying(Nanchang University), Siping Zhang(Anhui Provincial Hospital), Wenqing Wang(Hebei Medical University), Yanling Li(Hebei Medical University), Zudong Meng(People's Hospital of Shiyan), Hongyi Li, Kuanhou Mou(First Affiliated Hospital of Xi'an Jiaotong University), Xiuping Han(China Medical University), Shanshan Li(Jilin University), Aijun Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xin Li(Shanghai University of Traditional Chinese Medicine), Donghua Liu(Guangxi Medical University), Chunlei Zhang(Peking University), Chao Ji(Fujian Medical University), Yu Wang(Guiyang Medical University), Hao Cheng(Sir Run Run Shaw Hospital), Xiaojing Cui(Jiangsu Hengrui Medicine (China)), Xiaoyan Yao(Jiangsu Hengrui Medicine (China)), Xiaoyan Bai(Jiangsu Hengrui Medicine (China)), Guangchao Dong(Jiangsu Hengrui Medicine (China)), Jinhua Xu(Huashan Hospital)
Journal of the American Academy of Dermatology
September 26, 2024
Cited by 22

Abstract


Related Papers

No related papers found

Powered by citation graph analysis